| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2045-06-23 |
| Par Value | 2000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 500.41 |
| Coupon | 5.25 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 996.815 |
| Min. Piece | Login |
| Min. Increment | Login |
This Baxalta Inc corporate bond has a 5.25% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 996.82 million USD and matures on June 23, 2045 with a last coupon date of FEB 28, 2020. |
Baxalta Inc, founded in 2015 and headquartered in Bannockburn, Illinois, is a biopharmaceutical company focused on developing and delivering innovative therapies for rare diseases and complex medical conditions. The company specializes in hematology, immunology, and oncology, offering a range of therapies, including significant advancements in treatments for bleeding disorders and immune deficiencies.